Global Inhalational Anesthesia Drugs Market Growth 2025-2031

December 2025 | 87 pages | ID: G15D2FBE42DEN
LP Information

Abstracts

The global Inhalational Anesthesia Drugs market size is predicted to grow from US$ 1323 million in 2025 to US$ 1579 million in 2031; it is expected to grow at a CAGR of 3.0% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

An inhalational anaesthetic is a chemical compound possessing general anaesthetic properties that can be delivered via inhalation.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LP Information, Inc. (LPI) ' newest research report, the “Inhalational Anesthesia Drugs Industry Forecast” looks at past sales and reviews total world Inhalational Anesthesia Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Inhalational Anesthesia Drugs sales for 2025 through 2031. With Inhalational Anesthesia Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Inhalational Anesthesia Drugs industry.

This Insight Report provides a comprehensive analysis of the global Inhalational Anesthesia Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Inhalational Anesthesia Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Inhalational Anesthesia Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Inhalational Anesthesia Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Inhalational Anesthesia Drugs.

This report presents a comprehensive overview, market shares, and growth opportunities of Inhalational Anesthesia Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Sevoflurane
• Desflurane
• Isoflurane
• Enflurane

Segmentation by Application:

• Hospitals
• Clinics
• Ambulatory Surgical Centers

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Baxter
• AbbVie
• Piramal Enterprises
• Halocarbon Products
• Jiangsu Hengrui Medicine
• Fresenius Kabi

Key Questions Addressed in this Report

What is the 10-year outlook for the global Inhalational Anesthesia Drugs market?

What factors are driving Inhalational Anesthesia Drugs market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Inhalational Anesthesia Drugs market opportunities vary by end market size?

How does Inhalational Anesthesia Drugs break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Inhalational Anesthesia Drugs Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Inhalational Anesthesia Drugs by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Inhalational Anesthesia Drugs by Country/Region, 2020, 2024 & 2031
2.2 Inhalational Anesthesia Drugs Segment by Type
  2.2.1 Sevoflurane
  2.2.2 Desflurane
  2.2.3 Isoflurane
  2.2.4 Enflurane
2.3 Inhalational Anesthesia Drugs Sales by Type
  2.3.1 Global Inhalational Anesthesia Drugs Sales Market Share by Type (2020-2025)
  2.3.2 Global Inhalational Anesthesia Drugs Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Inhalational Anesthesia Drugs Sale Price by Type (2020-2025)
2.4 Inhalational Anesthesia Drugs Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
  2.4.3 Ambulatory Surgical Centers
2.5 Inhalational Anesthesia Drugs Sales by Application
  2.5.1 Global Inhalational Anesthesia Drugs Sale Market Share by Application (2020-2025)
  2.5.2 Global Inhalational Anesthesia Drugs Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Inhalational Anesthesia Drugs Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Inhalational Anesthesia Drugs Breakdown Data by Company
  3.1.1 Global Inhalational Anesthesia Drugs Annual Sales by Company (2020-2025)
  3.1.2 Global Inhalational Anesthesia Drugs Sales Market Share by Company (2020-2025)
3.2 Global Inhalational Anesthesia Drugs Annual Revenue by Company (2020-2025)
  3.2.1 Global Inhalational Anesthesia Drugs Revenue by Company (2020-2025)
  3.2.2 Global Inhalational Anesthesia Drugs Revenue Market Share by Company (2020-2025)
3.3 Global Inhalational Anesthesia Drugs Sale Price by Company
3.4 Key Manufacturers Inhalational Anesthesia Drugs Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Inhalational Anesthesia Drugs Product Location Distribution
  3.4.2 Players Inhalational Anesthesia Drugs Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR INHALATIONAL ANESTHESIA DRUGS BY GEOGRAPHIC REGION

4.1 World Historic Inhalational Anesthesia Drugs Market Size by Geographic Region (2020-2025)
  4.1.1 Global Inhalational Anesthesia Drugs Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Inhalational Anesthesia Drugs Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Inhalational Anesthesia Drugs Market Size by Country/Region (2020-2025)
  4.2.1 Global Inhalational Anesthesia Drugs Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Inhalational Anesthesia Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Inhalational Anesthesia Drugs Sales Growth
4.4 APAC Inhalational Anesthesia Drugs Sales Growth
4.5 Europe Inhalational Anesthesia Drugs Sales Growth
4.6 Middle East & Africa Inhalational Anesthesia Drugs Sales Growth

5 AMERICAS

5.1 Americas Inhalational Anesthesia Drugs Sales by Country
  5.1.1 Americas Inhalational Anesthesia Drugs Sales by Country (2020-2025)
  5.1.2 Americas Inhalational Anesthesia Drugs Revenue by Country (2020-2025)
5.2 Americas Inhalational Anesthesia Drugs Sales by Type (2020-2025)
5.3 Americas Inhalational Anesthesia Drugs Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Inhalational Anesthesia Drugs Sales by Region
  6.1.1 APAC Inhalational Anesthesia Drugs Sales by Region (2020-2025)
  6.1.2 APAC Inhalational Anesthesia Drugs Revenue by Region (2020-2025)
6.2 APAC Inhalational Anesthesia Drugs Sales by Type (2020-2025)
6.3 APAC Inhalational Anesthesia Drugs Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Inhalational Anesthesia Drugs by Country
  7.1.1 Europe Inhalational Anesthesia Drugs Sales by Country (2020-2025)
  7.1.2 Europe Inhalational Anesthesia Drugs Revenue by Country (2020-2025)
7.2 Europe Inhalational Anesthesia Drugs Sales by Type (2020-2025)
7.3 Europe Inhalational Anesthesia Drugs Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Inhalational Anesthesia Drugs by Country
  8.1.1 Middle East & Africa Inhalational Anesthesia Drugs Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Inhalational Anesthesia Drugs Revenue by Country (2020-2025)
8.2 Middle East & Africa Inhalational Anesthesia Drugs Sales by Type (2020-2025)
8.3 Middle East & Africa Inhalational Anesthesia Drugs Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Inhalational Anesthesia Drugs
10.3 Manufacturing Process Analysis of Inhalational Anesthesia Drugs
10.4 Industry Chain Structure of Inhalational Anesthesia Drugs

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Inhalational Anesthesia Drugs Distributors
11.3 Inhalational Anesthesia Drugs Customer

12 WORLD FORECAST REVIEW FOR INHALATIONAL ANESTHESIA DRUGS BY GEOGRAPHIC REGION

12.1 Global Inhalational Anesthesia Drugs Market Size Forecast by Region
  12.1.1 Global Inhalational Anesthesia Drugs Forecast by Region (2026-2031)
  12.1.2 Global Inhalational Anesthesia Drugs Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Inhalational Anesthesia Drugs Forecast by Type (2026-2031)
12.7 Global Inhalational Anesthesia Drugs Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Baxter
  13.1.1 Baxter Company Information
  13.1.2 Baxter Inhalational Anesthesia Drugs Product Portfolios and Specifications
  13.1.3 Baxter Inhalational Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Baxter Main Business Overview
  13.1.5 Baxter Latest Developments
13.2 AbbVie
  13.2.1 AbbVie Company Information
  13.2.2 AbbVie Inhalational Anesthesia Drugs Product Portfolios and Specifications
  13.2.3 AbbVie Inhalational Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 AbbVie Main Business Overview
  13.2.5 AbbVie Latest Developments
13.3 Piramal Enterprises
  13.3.1 Piramal Enterprises Company Information
  13.3.2 Piramal Enterprises Inhalational Anesthesia Drugs Product Portfolios and Specifications
  13.3.3 Piramal Enterprises Inhalational Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Piramal Enterprises Main Business Overview
  13.3.5 Piramal Enterprises Latest Developments
13.4 Halocarbon Products
  13.4.1 Halocarbon Products Company Information
  13.4.2 Halocarbon Products Inhalational Anesthesia Drugs Product Portfolios and Specifications
  13.4.3 Halocarbon Products Inhalational Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Halocarbon Products Main Business Overview
  13.4.5 Halocarbon Products Latest Developments
13.5 Jiangsu Hengrui Medicine
  13.5.1 Jiangsu Hengrui Medicine Company Information
  13.5.2 Jiangsu Hengrui Medicine Inhalational Anesthesia Drugs Product Portfolios and Specifications
  13.5.3 Jiangsu Hengrui Medicine Inhalational Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Jiangsu Hengrui Medicine Main Business Overview
  13.5.5 Jiangsu Hengrui Medicine Latest Developments
13.6 Fresenius Kabi
  13.6.1 Fresenius Kabi Company Information
  13.6.2 Fresenius Kabi Inhalational Anesthesia Drugs Product Portfolios and Specifications
  13.6.3 Fresenius Kabi Inhalational Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Fresenius Kabi Main Business Overview
  13.6.5 Fresenius Kabi Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Inhalational Anesthesia Drugs Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Inhalational Anesthesia Drugs Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Sevoflurane
Table 4. Major Players of Desflurane
Table 5. Major Players of Isoflurane
Table 6. Major Players of Enflurane
Table 7. Global Inhalational Anesthesia Drugs Sales by Type (2020-2025) & (K MT)
Table 8. Global Inhalational Anesthesia Drugs Sales Market Share by Type (2020-2025)
Table 9. Global Inhalational Anesthesia Drugs Revenue by Type (2020-2025) & ($ million)
Table 10. Global Inhalational Anesthesia Drugs Revenue Market Share by Type (2020-2025)
Table 11. Global Inhalational Anesthesia Drugs Sale Price by Type (2020-2025) & (USD/MT)
Table 12. Global Inhalational Anesthesia Drugs Sale by Application (2020-2025) & (K MT)
Table 13. Global Inhalational Anesthesia Drugs Sale Market Share by Application (2020-2025)
Table 14. Global Inhalational Anesthesia Drugs Revenue by Application (2020-2025) & ($ million)
Table 15. Global Inhalational Anesthesia Drugs Revenue Market Share by Application (2020-2025)
Table 16. Global Inhalational Anesthesia Drugs Sale Price by Application (2020-2025) & (USD/MT)
Table 17. Global Inhalational Anesthesia Drugs Sales by Company (2020-2025) & (K MT)
Table 18. Global Inhalational Anesthesia Drugs Sales Market Share by Company (2020-2025)
Table 19. Global Inhalational Anesthesia Drugs Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Inhalational Anesthesia Drugs Revenue Market Share by Company (2020-2025)
Table 21. Global Inhalational Anesthesia Drugs Sale Price by Company (2020-2025) & (USD/MT)
Table 22. Key Manufacturers Inhalational Anesthesia Drugs Producing Area Distribution and Sales Area
Table 23. Players Inhalational Anesthesia Drugs Products Offered
Table 24. Inhalational Anesthesia Drugs Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Inhalational Anesthesia Drugs Sales by Geographic Region (2020-2025) & (K MT)
Table 28. Global Inhalational Anesthesia Drugs Sales Market Share Geographic Region (2020-2025)
Table 29. Global Inhalational Anesthesia Drugs Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Inhalational Anesthesia Drugs Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Inhalational Anesthesia Drugs Sales by Country/Region (2020-2025) & (K MT)
Table 32. Global Inhalational Anesthesia Drugs Sales Market Share by Country/Region (2020-2025)
Table 33. Global Inhalational Anesthesia Drugs Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Inhalational Anesthesia Drugs Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Inhalational Anesthesia Drugs Sales by Country (2020-2025) & (K MT)
Table 36. Americas Inhalational Anesthesia Drugs Sales Market Share by Country (2020-2025)
Table 37. Americas Inhalational Anesthesia Drugs Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Inhalational Anesthesia Drugs Sales by Type (2020-2025) & (K MT)
Table 39. Americas Inhalational Anesthesia Drugs Sales by Application (2020-2025) & (K MT)
Table 40. APAC Inhalational Anesthesia Drugs Sales by Region (2020-2025) & (K MT)
Table 41. APAC Inhalational Anesthesia Drugs Sales Market Share by Region (2020-2025)
Table 42. APAC Inhalational Anesthesia Drugs Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Inhalational Anesthesia Drugs Sales by Type (2020-2025) & (K MT)
Table 44. APAC Inhalational Anesthesia Drugs Sales by Application (2020-2025) & (K MT)
Table 45. Europe Inhalational Anesthesia Drugs Sales by Country (2020-2025) & (K MT)
Table 46. Europe Inhalational Anesthesia Drugs Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Inhalational Anesthesia Drugs Sales by Type (2020-2025) & (K MT)
Table 48. Europe Inhalational Anesthesia Drugs Sales by Application (2020-2025) & (K MT)
Table 49. Middle East & Africa Inhalational Anesthesia Drugs Sales by Country (2020-2025) & (K MT)
Table 50. Middle East & Africa Inhalational Anesthesia Drugs Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Inhalational Anesthesia Drugs Sales by Type (2020-2025) & (K MT)
Table 52. Middle East & Africa Inhalational Anesthesia Drugs Sales by Application (2020-2025) & (K MT)
Table 53. Key Market Drivers & Growth Opportunities of Inhalational Anesthesia Drugs
Table 54. Key Market Challenges & Risks of Inhalational Anesthesia Drugs
Table 55. Key Industry Trends of Inhalational Anesthesia Drugs
Table 56. Inhalational Anesthesia Drugs Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Inhalational Anesthesia Drugs Distributors List
Table 59. Inhalational Anesthesia Drugs Customer List
Table 60. Global Inhalational Anesthesia Drugs Sales Forecast by Region (2026-2031) & (K MT)
Table 61. Global Inhalational Anesthesia Drugs Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Inhalational Anesthesia Drugs Sales Forecast by Country (2026-2031) & (K MT)
Table 63. Americas Inhalational Anesthesia Drugs Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Inhalational Anesthesia Drugs Sales Forecast by Region (2026-2031) & (K MT)
Table 65. APAC Inhalational Anesthesia Drugs Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Inhalational Anesthesia Drugs Sales Forecast by Country (2026-2031) & (K MT)
Table 67. Europe Inhalational Anesthesia Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Inhalational Anesthesia Drugs Sales Forecast by Country (2026-2031) & (K MT)
Table 69. Middle East & Africa Inhalational Anesthesia Drugs Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Inhalational Anesthesia Drugs Sales Forecast by Type (2026-2031) & (K MT)
Table 71. Global Inhalational Anesthesia Drugs Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Inhalational Anesthesia Drugs Sales Forecast by Application (2026-2031) & (K MT)
Table 73. Global Inhalational Anesthesia Drugs Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Baxter Basic Information, Inhalational Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 75. Baxter Inhalational Anesthesia Drugs Product Portfolios and Specifications
Table 76. Baxter Inhalational Anesthesia Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 77. Baxter Main Business
Table 78. Baxter Latest Developments
Table 79. AbbVie Basic Information, Inhalational Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. AbbVie Inhalational Anesthesia Drugs Product Portfolios and Specifications
Table 81. AbbVie Inhalational Anesthesia Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 82. AbbVie Main Business
Table 83. AbbVie Latest Developments
Table 84. Piramal Enterprises Basic Information, Inhalational Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Piramal Enterprises Inhalational Anesthesia Drugs Product Portfolios and Specifications
Table 86. Piramal Enterprises Inhalational Anesthesia Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. Piramal Enterprises Main Business
Table 88. Piramal Enterprises Latest Developments
Table 89. Halocarbon Products Basic Information, Inhalational Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Halocarbon Products Inhalational Anesthesia Drugs Product Portfolios and Specifications
Table 91. Halocarbon Products Inhalational Anesthesia Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 92. Halocarbon Products Main Business
Table 93. Halocarbon Products Latest Developments
Table 94. Jiangsu Hengrui Medicine Basic Information, Inhalational Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Jiangsu Hengrui Medicine Inhalational Anesthesia Drugs Product Portfolios and Specifications
Table 96. Jiangsu Hengrui Medicine Inhalational Anesthesia Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 97. Jiangsu Hengrui Medicine Main Business
Table 98. Jiangsu Hengrui Medicine Latest Developments
Table 99. Fresenius Kabi Basic Information, Inhalational Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Fresenius Kabi Inhalational Anesthesia Drugs Product Portfolios and Specifications
Table 101. Fresenius Kabi Inhalational Anesthesia Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 102. Fresenius Kabi Main Business
Table 103. Fresenius Kabi Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Inhalational Anesthesia Drugs
Figure 2. Inhalational Anesthesia Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Inhalational Anesthesia Drugs Sales Growth Rate 2020-2031 (K MT)
Figure 7. Global Inhalational Anesthesia Drugs Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Inhalational Anesthesia Drugs Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Inhalational Anesthesia Drugs Sales Market Share by Country/Region (2024)
Figure 10. Inhalational Anesthesia Drugs Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Sevoflurane
Figure 12. Product Picture of Desflurane
Figure 13. Product Picture of Isoflurane
Figure 14. Product Picture of Enflurane
Figure 15. Global Inhalational Anesthesia Drugs Sales Market Share by Type in 2025
Figure 16. Global Inhalational Anesthesia Drugs Revenue Market Share by Type (2020-2025)
Figure 17. Inhalational Anesthesia Drugs Consumed in Hospitals
Figure 18. Global Inhalational Anesthesia Drugs Market: Hospitals (2020-2025) & (K MT)
Figure 19. Inhalational Anesthesia Drugs Consumed in Clinics
Figure 20. Global Inhalational Anesthesia Drugs Market: Clinics (2020-2025) & (K MT)
Figure 21. Inhalational Anesthesia Drugs Consumed in Ambulatory Surgical Centers
Figure 22. Global Inhalational Anesthesia Drugs Market: Ambulatory Surgical Centers (2020-2025) & (K MT)
Figure 23. Global Inhalational Anesthesia Drugs Sale Market Share by Application (2024)
Figure 24. Global Inhalational Anesthesia Drugs Revenue Market Share by Application in 2025
Figure 25. Inhalational Anesthesia Drugs Sales by Company in 2025 (K MT)
Figure 26. Global Inhalational Anesthesia Drugs Sales Market Share by Company in 2025
Figure 27. Inhalational Anesthesia Drugs Revenue by Company in 2025 ($ millions)
Figure 28. Global Inhalational Anesthesia Drugs Revenue Market Share by Company in 2025
Figure 29. Global Inhalational Anesthesia Drugs Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Inhalational Anesthesia Drugs Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Inhalational Anesthesia Drugs Sales 2020-2025 (K MT)
Figure 32. Americas Inhalational Anesthesia Drugs Revenue 2020-2025 ($ millions)
Figure 33. APAC Inhalational Anesthesia Drugs Sales 2020-2025 (K MT)
Figure 34. APAC Inhalational Anesthesia Drugs Revenue 2020-2025 ($ millions)
Figure 35. Europe Inhalational Anesthesia Drugs Sales 2020-2025 (K MT)
Figure 36. Europe Inhalational Anesthesia Drugs Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Inhalational Anesthesia Drugs Sales 2020-2025 (K MT)
Figure 38. Middle East & Africa Inhalational Anesthesia Drugs Revenue 2020-2025 ($ millions)
Figure 39. Americas Inhalational Anesthesia Drugs Sales Market Share by Country in 2025
Figure 40. Americas Inhalational Anesthesia Drugs Revenue Market Share by Country (2020-2025)
Figure 41. Americas Inhalational Anesthesia Drugs Sales Market Share by Type (2020-2025)
Figure 42. Americas Inhalational Anesthesia Drugs Sales Market Share by Application (2020-2025)
Figure 43. United States Inhalational Anesthesia Drugs Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Inhalational Anesthesia Drugs Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Inhalational Anesthesia Drugs Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Inhalational Anesthesia Drugs Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Inhalational Anesthesia Drugs Sales Market Share by Region in 2025
Figure 48. APAC Inhalational Anesthesia Drugs Revenue Market Share by Region (2020-2025)
Figure 49. APAC Inhalational Anesthesia Drugs Sales Market Share by Type (2020-2025)
Figure 50. APAC Inhalational Anesthesia Drugs Sales Market Share by Application (2020-2025)
Figure 51. China Inhalational Anesthesia Drugs Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Inhalational Anesthesia Drugs Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Inhalational Anesthesia Drugs Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Inhalational Anesthesia Drugs Revenue Growth 2020-2025 ($ millions)
Figure 55. India Inhalational Anesthesia Drugs Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Inhalational Anesthesia Drugs Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Inhalational Anesthesia Drugs Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Inhalational Anesthesia Drugs Sales Market Share by Country in 2025
Figure 59. Europe Inhalational Anesthesia Drugs Revenue Market Share by Country (2020-2025)
Figure 60. Europe Inhalational Anesthesia Drugs Sales Market Share by Type (2020-2025)
Figure 61. Europe Inhalational Anesthesia Drugs Sales Market Share by Application (2020-2025)
Figure 62. Germany Inhalational Anesthesia Drugs Revenue Growth 2020-2025 ($ millions)
Figure 63. France Inhalational Anesthesia Drugs Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Inhalational Anesthesia Drugs Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Inhalational Anesthesia Drugs Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Inhalational Anesthesia Drugs Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Inhalational Anesthesia Drugs Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Inhalational Anesthesia Drugs Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Inhalational Anesthesia Drugs Sales Market Share by Application (2020-2025)
Figure 70. Egypt Inhalational Anesthesia Drugs Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Inhalational Anesthesia Drugs Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Inhalational Anesthesia Drugs Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Inhalational Anesthesia Drugs Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Inhalational Anesthesia Drugs Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Inhalational Anesthesia Drugs in 2025
Figure 76. Manufacturing Process Analysis of Inhalational Anesthesia Drugs
Figure 77. Industry Chain Structure of Inhalational Anesthesia Drugs
Figure 78. Channels of Distribution
Figure 79. Global Inhalational Anesthesia Drugs Sales Market Forecast by Region (2026-2031)
Figure 80. Global Inhalational Anesthesia Drugs Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Inhalational Anesthesia Drugs Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Inhalational Anesthesia Drugs Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Inhalational Anesthesia Drugs Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Inhalational Anesthesia Drugs Revenue Market Share Forecast by Application (2026-2031)